The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Secretory leucoprotease inhibitor binds to NF-κB binding sites in monocytes and inhibits p65 binding
Open accessAbstract
Secretory leucoprotease inhibitor (SLPI) is a nonglycosylated protein produced by epithelial cells. In addition to its antiprotease activity, SLPI has been shown to exhibit antiinflammatory properties, including down-regulation of tumor necrosis factor α expression by lipopolysaccharide (LPS) in macrophages and inhibition of nuclear factor (NF)-κB activation in a rat model of acute lung injury. We have previously shown that SLPI can inhibit LPS-induced NF-κB activation in monocytic cells by inhibiting degradation of IκBα without affecting the LPS-induced phosphorylation and ubiquitination of IκBα. Here, we present evidence to show that upon incubation with peripheral blood monocytes (PBMs) and the U937 monocytic cell line, SLPI enters the cells, becoming rapidly localized to the cytoplasm and nucleus, and affects NF-κB activation by binding directly to NF-κB binding sites in a site-specific manner. SLPI can also prevent p65 interaction with the NF-κB consensus region at concentrations commensurate with the physiological nuclear levels of SLPI and p65. We also demonstrate the presence of SLPI in nuclear fractions of PBMs and alveolar macrophages from individuals with cystic fibrosis and community-acquired pneumonia. Therefore, SLPI inhibition of NF-κB activation is mediated, in part, by competitive binding to the NF-κB consensus-binding site.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Polyarginine enters cells more efficiently than other polycationic homopolymers
Mitchell, D. J., Steinman, L., Kim, D. T., Fathman, C. G., & Rothbard, J. B. (2000) · The Journal of Peptide Research · doi:10.1034/j.1399-3011.2000.00723.x · Cited by 1,084
GUPTA, B., LEVCHENKO, T., & TORCHILIN, V (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2004.10.007 · Cited by 632
McNeely, T. B., Dealy, M., Dripps, D. J., Orenstein, J. M., Eisenberg, S. P., & Wahl, S. M. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118056 · Cited by 436
Possible Existence of Common Internalization Mechanisms among Arginine-rich Peptides
Suzuki, T., Futaki, S., Niwa, M., Tanaka, S., Ueda, K., & Sugiura, Y. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m110017200 · Cited by 430
Jin, F.-Y., Nathan, C., Radzioch, D., & Ding, A. (1997) · Cell · doi:10.1016/s0092-8674(00)81880-2 · Cited by 400
Sequence specificity and transcriptional activation in the binding of lactoferrin to DNA
He, J., & Furmanski, P. (1995) · Nature · doi:10.1038/373721a0 · Cited by 354
McElvaney, N. G., Nakamura, H., Birrer, P., Hébert, C. A., Wong, W. L., Alphonso, M., Baker, J. B., Catalano, M. A., & Crystal, R. G. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115994 · Cited by 299
Self-citationBrightbill, H. D., Plevy, S. E., Modlin, R. L., & Smale, S. T. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.4.1940 · Cited by 268
McNeely, T. B., Shugars, D. C., Rosendahl, M., Tucker, C., Eisenberg, S. P., & Wahl, S. M. (1997) · Blood · doi:10.1182/blood.v90.3.1141 · Cited by 253
Bowdish, D. M. E., Davidson, D. J., Speert, D. P., & Hancock, R. E. W. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.6.3758 · Cited by 233
Cited by
The role of sex hormones in immune protection of the female reproductive tract
Wira, C. R., Rodriguez-Garcia, M., & Patel, M. V. (2015) · Nature Reviews Immunology · doi:10.1038/nri3819 · Cited by 444
Xu, W., He, B., Chiu, A., Chadburn, A., Shan, M., Buldys, M., Ding, A., Knowles, D. M., Santini, P. A., & Cerutti, A. (2007) · Nature Immunology · doi:10.1038/ni1434 · Cited by 306
Tumor necrosis factor‐alpha (TNF‐α) is a therapeutic target for impaired cutaneous wound healing
Ashcroft, G. S., Jeong, M., Ashworth, J. J., Hardman, M., Jin, W., Moutsopoulos, N., Wild, T., McCartney‐Francis, N., Sim, D., McGrady, G., et al. (2012) · Wound Repair and Regeneration · doi:10.1111/j.1524-475x.2011.00748.x · Cited by 285
Transcriptional Control of the TNF Gene
Falvo, J. V., Tsytsykova, A. V., & Goldfeld, A. E. (2010) · Current Directions in Autoimmunity · doi:10.1159/000289196 · Cited by 281
Novel role for SLPI in MOG-induced EAE revealed by spinal cord expression analysis
Mueller, A. M., Pedré, X., Stempfl, T., Kleiter, I., Couillard-Despres, S., Aigner, L., Giegerich, G., & Steinbrecher, A. (2008) · Journal of Neuroinflammation · doi:10.1186/1742-2094-5-20 · Cited by 61
“... induced and increased proliferation of adult NSCs, associated with the selective induction of the growth-promoting factor cyclin D1. The latter effect is probably not caused solely by SLPI's inhibitory action on proteases, because α1-antitrypsin, a comparable protease inhibitor [46], did not cause a similar upregu…”
Background
Metadata
- Authors
- Taggart, C. C., Cryan, S.-A., Weldon, S., Gibbons, A., Greene, C. M., Kelly, E., Low, T. B., O'Neill, S. J., & McElvaney, N. G.
- Venue
- The Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2005-12-13
- Volume
- 202
- Issue
- 12
- Pages
- 1659-1668
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2172191093
- Cited by
- 257
- References
- 31
- FWCI
- 2.67
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Secretory leucoprotease inhibitor binds to NF-κB binding sites in monocytes and inhibits p65 binding. https://app.cochat.ai/papers/10.1084/jem.20050768
- The paper
- Taggart, C. C., Cryan, S.-A., Weldon, S., Gibbons, A., Greene, C. M., Kelly, E., Low, T. B., O'Neill, S. J., & McElvaney, N. G. (2005). Secretory leucoprotease inhibitor binds to NF-κB binding sites in monocytes and inhibits p65 binding. The Journal of Experimental Medicine. https://doi.org/10.1084/jem.20050768
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.